Analyst Ratings for ResMed (RMD)
RMD Rating Summary
RMD Price Target Summary
- Highest: $300.00 (UBS)
- Lowest: $180.00 (Wolfe Research)
- Average: $233.17
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$233.17 (-1.4%)
* Over Last 12-Mos
Rating Score: 4.2 / 10
Percentile Rank: 41%
Avg. $ Target:
$233.17 (-1.4%)
* Over Last 12-Mos
Rating Score: 4.2 / 10
Percentile Rank: 41%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/19/2026 | Rothschild Redburn | Jackson Philips | New Coverage | Neutral (N/A) |
230.00 (N/A) |
220.37 (236.49) |
7.31% | Details |
| 7/16/2026 | RBC Capital » Updated 8/7/2026 |
Craig Wong-Pan | Downgrade | Sector Perform (Outperform) |
244.00 (234.00) |
198.57 (236.49) |
19.1% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
